The isCGM Use and Hypoglycemic Episodes and Fear of Hypoglycemia in Newly Diagnosed Type 1 Diabetes - Trial NCT06414824
Access comprehensive clinical trial information for NCT06414824 through Pure Global AI's free database. This phase not specified trial is sponsored by Jagiellonian University and is currently Recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Jagiellonian University
Timeline & Enrollment
N/A
May 01, 2022
Dec 01, 2024
Primary Outcome
Hypoglycemia Fear Survey II,TBR 70 mg/dL
Summary
The aim of this trial is to investigate the impact of FreeStyle Libre use compared to SMBG on
 hypoglycemia episodes and fear of hypoglycemia in adults aged 18-35 with newly diagnosed type
 1 diabetes.
 
 This trial is conducted in university centers in Poland (Bialystok, Krakow, Poznan, Zabrze).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06414824
Device Trial